Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

MindMed

Biotech & Life Sciences · New York City, United States · Founded 2019 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.43B
Market cap · Mar/2026

Investors

19 investors on MindMed's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage
Kevin O'Leary
Bruce Linton
Series B+ 17 investors entered at this stage
Canaccord Genuity
Cannell Capital
Soleus Capital
Bail Capital
Driehaus Capital Management
Great Point Partners
Octagon Capital Partners
Ally Bridge Group
Blake Mycoskie
Special Situations Funds
Leerink Partners
Janus Henderson Investors
Deep Track Capital
Woodline Partners
Marshall Wace
Commodore Capital
Cantor Fitzgerald

Global footprint

Where MindMed has talent and traffic

Web traffic by country
16K monthly visits
across markets
🇺🇸 United States56.3%
🇨🇦 Canada14.4%
🇩🇪 Germany11.9%
🇳🇱 Netherlands6.9%
🇮🇳 India5.6%
Top 5 markets shown

See MindMed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo